Guidance for Industry and Food and Drug Administration Staff – Factors to Consider When Making Benefit

%PDF-1.7% 5062 0 objstream h}sGiTYo}bq.~Y`x9C=HCHb7H@Yۥꬬ쪧aPISkԅH5,DVBXHZ֊?Ki/4mYhU:aa:_,,kh-[XڷͼfE_Ɩw*udH.Kk”kjI[,rU~[b}.JZ_e=x鳼1ZLZkXԚbXRբ,v^`֮Rb(C}tɝ,$jȩ}0w4xGEx,ެ8XTKYvr3#9Z(~a26݂[,g%yv,$Ji=+~kJKTY I6^SkSv{Tfׯ#Fc[zja’1RZ()uzIXGsxgxw ZkzPsoZ,W.偟څ=sZTUښ_4aThGLMO J3Qx,4gJF_O3#MV)v5ޛrH}]790js,iG{G46Z|hnwMvǎqT-ӅZX=^275a:N~,Z.Lݚs|똌qVݸJy’Ʀ”_IA[}Z1g骧KKSxZBgYw}%x26j5[aԯZ3|fQm?Ʀ 6O1a=kZтߠ’֝K6Ư’E’cֱ~dqtm$ 2zrЖKKb3!Ѯ69l7ZzSCnʇ1(|ӹc$.Zctnr鏔 ӹC{δ7,Lasyz2LZyJs]C_“U#!2JajWsotb28=͘98ş Y97g:Oخ|֮cn]@T|yzoOܲ2fHcyz?[Gw7|勝mxã[?ohnmN,lg᫟}o{;?=Q8Mg_kZ=xw7_[.?ޢ=F-Ƴv0wvcؑb-0uMMgW;o}߉+OT0|_A9Sh;6z`?ws}Xp7$u=/07D{-2c”αO840?Lgn?71 ;n’)yS{${3$tW~#7uRls[݃#4ѧw^on77W^nl_mx?ӍNz{|u{4^˭v)W^r}葴?Ѧ]Gi.?G9޸|Ӎv{r7Y߻G[?[kq{߂=~”4OP^o0Ym08yp;i`sL0ڜ3 pwmzqLq}xh)yqp؎qib.ڛ}=LJ-C=ǃ{~~_ˍ^l-nܡcCNm?Z[LqT/$;h[{/u}ulv67|sk{{`hZ|Z!_zpix=7WSR9E`/h1Nj?ߴ;֞/ش =eZeݩrПuDzN,mM÷|֋`ynAW’;UwH }SZq~=ә?~ޗ ;r3_70v8|^[kvɥuYT svNޟ:Ab:eo6m[س{1Wƿ1]s֋鞎yuâm^^noxņ]RzvW{;]w/Ǯ,o={f֋gu_F9xhtv%Y.}]bhߟ}W,-6_/۲z{޽{)}FH{C~0yVj͟d %z~,|3`gxkhc{g;mo?͍[zƜrv3l83dCY?_o}~noЗrz,kު0x}ʅw V.oL^lLd*~Ə {d1EEI;Jl2”NNVz ڕpM/0VעFECxW’]l;yܔCg%.`77~yy}{׍W/_,v64Hinݭ~s~t-˝gEqR~y1}vӷ|ۺֻb’EIY]C8wק[zSqY?ڎ{ս}o[TsdX9SLfcevQs!T( *NOD(*#]Ap5ۦuʊ_tu(VP,!}!ZM)O[)j菳RGM;Gl]+?oN%fܶTv”Je2gf䡟)RAwR8u} W_[1՜RNZYP8Z?N7[?#G~}tyNWIϷگ!J/4*Bh$,LɹW5+3.㻏؍GgQ#]GYQZ?D^n ^e_PʾZK;Ch1OGeů`}`AH5N9y(y%~ıJ[Kc7}~K`K.ۀK,?qS!E|~{P.8ZWW(ABy.̱ (sl(qxe} WſW߲zl”EѺqkW{nʩÏշdw^l=o:TƾlҰn%/Ć[7)Oofkw7^|3ѧ.Ҽpp߹~笫NoO1~;^7skRwAav7!%r~nBx8Mz`wo3{W{z|͝O6z~Q-޻˹a~!Xi*Q?n35} 7Yq}”MW,cj1d;zyow:{_7 ӽ̧#’3_[!1½GH!w:@:1L]|?|͗^sTr67Ssk#Lg?~ޗS|K~UNġ88y*+ [j%mע˰U@t88kn8qάK@eOUTk~C3oӳKӣ’Y.ǻZ,:W/s Wa4LШ4:(OO”-QFK5d5˼Ȇebd23àٰd2o:r2LOXv=g,SĞ3f;sT0З%B! PHB”Jw1 PHB”D($B! PHB”D($B! PHB”D($B! PHB”D($B! PHS(8Efzdx”`D#J_2Fd0″`D#2Fd0″`D#2Fd0″”ȨDF%2*QJdT”rbQYip fjdFSdFfj$GhdFhd+A^K$H7f/_V2d/_~12,)#.3fp2+X.XƉ3MÛ6{15l2oLXr,SgH-_k

Amendment of Notice Announcement : September 15, 2016 National Mammography Quality Assurance Advisory Committee Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2016-N-0001] National Mammography Quality Assurance Advisory Committee; Amendment of Notice AGENCY:  Food and Drug Administration, HHS. ACTION:  Notice. SUMMARY:  The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the National Mammography Quality Assurance Advisory Committee.  This…

Public Workshop – Adapting Regulatory Oversight of Next Generation Sequencing-Based Tests

The Food and Drug Administration is announcing the following public workshop entitled: “Adapting Regulatory Oversight of Next Generation Sequencing-Based Tests”. The purpose of this workshop is to obtain feedback on two FDA draft guidances, “Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases”…

Consumer Information on: Edwards SAPIEN 3 Transcatheter Heart Valve

This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. Product Name: Edwards SAPIEN 3 Transcatheter Heart…

Consumer Information on: Edwards SAPIEN XT Transcatheter Heart Valve

This is a brief overview of information related to FDA’s approval to market this product. See the links below to the Summary of Safety and Effectiveness Data (SSED) and product labeling for more complete information on this product, its indications for use, and the basis for FDA’s approval. Product Name: Edwards SAPIEN XT Transcatheter Heart…